Effect of statin therapy in patients with lung cancer on mortality, incidence of infections and pulmonary embolism Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Chemopreventive effect of long-term use of low-dose aspirin on lung cancer risk : A nationwide study considering competing risk Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality Source: ERJ Open Res, 7 (3) 00178-2021; 10.1183/23120541.00178-2021 Year: 2021
Interactions of smoking with other lung cancer risk factors in women Source: Eur Respir J 2006; 28: Suppl. 50, 454s Year: 2006
No impact of statins on time to first COPD exacerbation or all-cause mortality Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
Risk factors for early mortality in lung cancer Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012
Tiotropium and the risk of cardiovascular events and all-cause mortality Source: Annual Congress 2010 - Comorbidities and disease management in primary care Year: 2010
The risk of cardiovascular disease associated with asthma may be mediated by short-acting β2 -agonists Source: Annual Congress 2008 - Epidemiology of asthma and allergy Year: 2008
Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics Source: Eur Respir J 2001; 17: 380-385 Year: 2001
New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD Source: Eur Respir J, 53 (6) 1900717; 10.1183/13993003.00717-2019 Year: 2019
Does atorvastatin have effect on lung function and morbidity as add-on therapy in asthmatic patients? Source: Annual Congress 2007 - New drugs for asthma Year: 2007
Statin use associated with reduced risk of asthma: a meta-analysis Source: International Congress 2019 – Asthma and the world Year: 2019
Combination therapy of inhaled corticosteroids and long-acting beta2 -agonists may be associated with risk reduction of lung cancer in COPD patients who quit smoking Source: Eur Respir J 2006; 28: Suppl. 50, 454s Year: 2006
30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator? Source: ERJ Open Res, 4 (4) 00030-2018; 10.1183/23120541.00030-2018 Year: 2018
Pharmacological management and risk of mortality after first COPD hospitalization (HERA) Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020
Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients Source: Eur Respir J 2011; 37: 888-894 Year: 2011
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016 Year: 2017
Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD Source: Eur Respir J 2010; 35: 1003-1021 Year: 2010